Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
9.56B
Market cap9.56B
Price-Earnings ratio
17.76
Price-Earnings ratio17.76
Dividend yield
—
Dividend yield—
Average volume
2.94M
Average volume2.94M
High today
$73.45
High today$73.45
Low today
$71.72
Low today$71.72
Open price
$72.97
Open price$72.97
Volume
1.52M
Volume1.52M
52 Week high
$101.40
52 Week high$101.40
52 Week low
$70.40
52 Week low$70.40

Stock Snapshot

The current Globus Medical(GMED) stock price is $72.14, with a market capitalization of 9.56B. The stock trades at a price-to-earnings (P/E) ratio of 17.76.

On 2026-11-13, Globus Medical(GMED) stock traded between a low of $71.72 and a high of $73.45. Shares are currently priced at $72.14, which is +0.6% above the low and -1.8% below the high.

Globus Medical(GMED) shares are trading with a volume of 1.52M, against a daily average of 2.94M.

During the past year, Globus Medical(GMED) stock moved between $70.40 at its lowest and $101.40 at its peak.

During the past year, Globus Medical(GMED) stock moved between $70.40 at its lowest and $101.40 at its peak.

GMED News

TipRanks 4d
Globus Medical Earnings Call Highlights Growth Amid Near-Term Setbacks

Globus Medical ((GMED)) has held its Q3 earnings call. Read on for the main highlights of the call. Globus Medical delivered a broadly constructive third-quart...

Simply Wall St 5d
Globus Medical Following Guidance Cut Is The Selloff A Buying Opportunity

Globus Medical stock moves after guidance cut and acquisition push Globus Medical (GMED) has been in focus after third quarter 2026 results showed slightly sof...

Globus Medical Following Guidance Cut Is The Selloff A Buying Opportunity
Simply Wall St 6d
Globus Medical Stock May Be 32% Undervalued On Synaptive Deal

Globus Medical, , has seen its share price come under pressure this year, which puts a sharper spotlight on whether today's valuation is properly grounded in th...

Globus Medical Stock May Be 32% Undervalued On Synaptive Deal

Analyst ratings

65%

of 17 ratings
Buy
64.7%
Hold
35.3%
Sell
0%

More GMED News

Simply Wall St 7d
Globus Medical Stock Earnings Beat Meets Lower Revenue Outlook and Bigger Buyback

Globus Medical reported mixed third quarter 2026 results, with US$763.72 million in sales, higher net income and EPS, a reaffirmed EPS outlook and a lower full...

Globus Medical Stock Earnings Beat Meets Lower Revenue Outlook and Bigger Buyback

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.